Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimate renal cell carcinoma recurrence rates using electronic health records.

ESMO real world data and digital oncology·2026
Same author

Corrigendum to "Effect of prophylactic intravenous calcium gluconate on uterine atony during intrapartum cesarean delivery with spinal anesthesia: a placebo controlled, randomized clinical trial". [Int. J. Obst. Anesth. 63 (2025) 104704].

International journal of obstetric anesthesia·2025
Same author

Effect of prophylactic intravenous calcium gluconate on uterine atony during intrapartum cesarean delivery with spinal anesthesia: a placebo controlled, randomized clinical trial.

International journal of obstetric anesthesia·2025
Same author

Assessing Drug Utilization in the Emergency Medicine Department at a Tertiary Care Teaching Hospital Using WHO Drug Use Indicators.

Kathmandu University medical journal (KUMJ)·2024
Same author

Effects of dietary supplementation with omega-3 fatty acid-rich linseed on the reproductive performance of ewes in subtropical climates.

Frontiers in veterinary science·2024
Same author

Enhancing soil health and fruit yield through Tephrosia biomass mulching in rainfed guava (Psidium guajava L.) orchards.

Scientific reports·2024

Related Experiment Video

Updated: Jun 27, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Radiotherapy for benign diseases.

A K Jha1, R Prasiko, H Mod

  • 1Department of Radiation Oncology, BP Koirala Memorial Cancer Hospital, Bharatpur, Chitwan. anjani@operamail.com

JNMA; Journal of the Nepal Medical Association
|December 17, 2008
PubMed
Summary

Radiotherapy treats malignant tumors and some benign diseases, requiring careful consideration of radiation dose, time, and shielding. Special precautions are vital for pediatric patients and sensitive organs to minimize long-term risks.

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Related Experiment Videos

Last Updated: Jun 27, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Radiotherapy is a primary treatment for malignant tumors.
  • Despite known risks of ionizing radiation (skin injury, carcinogenesis, genetic damage), radiotherapy is also used for benign conditions.
  • Careful planning is essential before initiating radiation therapy.

Purpose of the Study:

  • To provide an overview of radiotherapy for benign conditions.
  • To highlight critical factors in radiation therapy planning.
  • To emphasize radiation protection principles.

Main Methods:

  • Review of radiotherapy principles and applications for benign diseases.
  • Discussion of factors influencing treatment quality (dose, time, shielding).
  • Emphasis on organ-at-risk considerations and radiation protection techniques.

Main Results:

  • Radiotherapy is a viable option for select benign conditions.
  • Optimizing beam penetration and energy is crucial for sparing normal tissue.
  • Specific organs (thyroid, eyes, gonads, bone marrow, breast) require utmost protection.

Conclusions:

  • Radiotherapy requires meticulous planning, especially regarding dose, time, and shielding.
  • Pediatric use of ionizing radiation should be exceptional and carefully evaluated.
  • Protecting radiosensitive organs and employing radiation protection techniques are paramount in all radiotherapy applications.